BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, June 22, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Replagal receives European approval for Fabry's disease
Aug. 9, 2001
Taisho patents compounds for treating bone or neurological diseases
Aug. 8, 2001
Genzyme receives marketing authorization for Fabrazyme
Aug. 8, 2001
Noven signs product development agreement with Novartis for combination HRT patches
Aug. 8, 2001
Novartis files Estradot in the European Union
Aug. 8, 2001
Memantine to be evaluated in the treatment of diabetic neuropathy
Aug. 3, 2001
Letrozole may increase adult height in boys with delayed puberty
Aug. 3, 2001
Abbott Laboratories submits NDA for Synthroid ahead of schedule
Aug. 3, 2001
Long-terms effects of Ac-SDKP assessed in rat model of renovascular hypertension
Aug. 3, 2001
Phase I trial of oral gluconeogenesis inhibitors for diabetes mellitus set to begin
Aug. 3, 2001
Previous
1
2
…
1416
1417
1418
1419
1420
1421
1422
1423
1424
…
1797
1798
Next
RSS